Michael Tansey, BSC, MB, ChB, M.D., FFPM, former chief medical officer of Pharmacia, has joined PhESi as a strategic partner.

Tansey is an established leader in the pharmaceutical industry, with extensive international  line management, strategic oversight, project development and process redesign experience in large global pharmaceutical, including Hoechst, GlaxoSmithKline, Rhone-Poulenc Rorer and Pharmacia, as well as in small to medium-sized biotechnology companies.

PhESi has built an extensive clinical development database, including the largest clinical trial site/investigator database, with over 500,000 independent investigators worldwide. Using patent protected method, PhESi Clinical Trial Site Selection Services consistently provide superior enrollment results to its clients.